Daisy Wolf

100% of stock trades used to be made by humans. Today, 80% are made by computer algorithms. AI is about to bring a similar revolution to healthcare. Over the next few decades, at least half of the $4.3 trillion dollar American healthcare industry will be AI-driven.

The 2010s era of VC-backed healthtech was largely an enterprise game, with most founders pursuing large payors, hospital systems, or jumbo employers as customers. This was because enterprises were the customers with enough budget and IT sophistication to justify VC-scale expectations on contract sizes and growth. But recently, selling to small-to-medium sized businesses (SMBs) has...

How are healthtech companies creating sustainable growth paths by selling to SMBs? Can companies solely rely on SMB sales to get to scale, or do they inevitably need to go upmarket (especially during challenging economic times)? We talked to Nancy Ham, the previous CEO of WebPT, Nate Maslak, CEO and…

We believe consumer health companies will win by being best-in-class in one of three areas: (1) how we access care, (2) how we receive care, or (3) how we pay for care.

We think there is an arbitrage opportunity for a player that sees the world differently. Poor engagement, which is caused by poor consumer experience, is the biggest problem in healthcare.